Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
0.5722
+0.0222 (4.04%)
At close: Apr 1, 2025, 4:00 PM
0.5749
+0.0027 (0.47%)
After-hours: Apr 1, 2025, 6:12 PM EDT
CNTB Revenue
In the year 2024, Connect Biopharma Holdings had annual revenue of $26.03M. Connect Biopharma Holdings had revenue of $24.12M in the half year ending June 30, 2024.
Revenue (ttm)
$26.03M
Revenue Growth
n/a
P/S Ratio
1.21
Revenue / Employee
$321,395
Employees
81
Market Cap
31.62M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
CNTB News
- 17 hours ago - Connect Biopharma Announces Positive Type C Meeting with the FDA for Rademikibart - GlobeNewsWire
- 1 day ago - Connect Biopharma Announces Publication of Positive Data from Global Phase 2 Trial of Rademikibart in Patients with Moderate-to-Severe Uncontrolled Asthma - GlobeNewsWire
- 1 day ago - Connect Biopharma Reports 2024 Full-Year Financial Results and Provides Business Update - GlobeNewsWire
- 4 days ago - Connect Biopharma Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement - GlobeNewsWire
- 4 weeks ago - Connect Biopharma to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 6 months ago - Attovia Therapeutics Appoints Chief Financial Officer - GlobeNewsWire
- 6 months ago - CNTB Stock Dips Amid Biotech Sector Volatility - GuruFocus
- 6 months ago - CNTB Stock Surges Over 5% Amid Strong Financial Performance - GuruFocus